Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Coronavirus (SARS-CoV)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT04510194
What this trial is testing

COVID-OUT: Early Outpatient Treatment for SARS-CoV-2 Infection (COVID-19)

Who this might be right for
Covid19SARS-CoV Infection
University of Minnesota 1,323
Not applicableUnknownNCT04672577
What this trial is testing

Infection Tracking in Travellers. The Project Aims to Identify Profiles of Travel-associated Illness and to Follow up on Long-term Sequelae of Arboviral Infections and Malaria

Who this might be right for
Travel-Related IllnessMalariaDengue+6 more
Patricia Schlagenhauf 10,000
Not applicableStudy completedNCT04832022
What this trial is testing

Longitudinal Follow-up of Patients With Chronic Inflammatory Rheumatisms (CIRs) Vaccinated Against COVID-19 Compared to Patients Refusing Vaccination

Who this might be right for
Rheumatic DiseasesSARS-CoV InfectionCOVID-19
University Hospital, Montpellier 397
Not applicableStudy completedNCT04603755
What this trial is testing

Electrical Impedance Tomography: Collapse in Dependent Areas as a Predictor of Response to Prone Position Ventilation in COVID-19 Acute Respiratory Distress Syndrome

Who this might be right for
SARS-CoV InfectionAcute Respiratory Distress Syndrome
Direction Centrale du Service de Santé des Armées 50
Early research (Phase 1)Study completedNCT05548439
What this trial is testing

Safety, Tolerability, and Immunogenicity of Trivalent Coronavirus Vaccine Candidate VBI-2901a

Who this might be right for
COVID-19Coronavirus Infections
VBI Vaccines Inc. 103
Large-scale testing (Phase 3)UnknownNCT04403100
What this trial is testing

Hydroxychloroquine and Lopinavir/ Ritonavir to Improve the Health of People With COVID-19: "The Hope Coalition - 1"

Who this might be right for
COVID-19Coronavirus InfectionVirus Disease+2 more
Cardresearch 1,968
Large-scale testing (Phase 3)Study completedNCT05148845
What this trial is testing

Sisonke 2 - A COVID-19 Vaccine Boost Open Label Study.

Who this might be right for
SARS CoV 2 Infection
Wits Health Consortium (Pty) Ltd 500,000
Not applicableUnknownNCT05835128
What this trial is testing

Assessment of Long-term Sequelae of Coronavirus Disease 2019 (COVID-19) Pneumonia With Chest CT and Pulmonary Function Tests

Who this might be right for
COVID-19 PneumoniaSequelae of; InfectionRespiratory Function Impaired+2 more
Centro Hospitalar Universitario do Algarve 250
Not applicableStudy completedNCT01056185
What this trial is testing

Respiratory Virus Hospitalization Study (FLU 003 Plus)

Who this might be right for
InfluenzaNovel Respiratory Virus-1 Middle Eastern Respiratory Syndrome Coronavirus (MERS-CoV)Novel Respiratory Virus-2 Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV)
University of Minnesota 1,000
Not applicableNo Longer AvailableNCT04372368
What this trial is testing

Convalescent Plasma for the Treatment of Patients With COVID-19

Who this might be right for
COVID-19SARS-CoV 2
University of Colorado, Denver
Not applicableStudy completedNCT05234359
What this trial is testing

The CHILD Cohort COVID-19 Add-On Study

Who this might be right for
SARS-CoV InfectionCovid19
University of Manitoba 5,385
Not applicableUnknownNCT04530461
What this trial is testing

Serologic Profile of SARS CoV2 in COVID-19 Patients With Systemic Diseases

Who this might be right for
SARS-CoV InfectionSystemic DiseaseSystemic Lupus Erythematosus+6 more
faida agili 200
Large-scale testing (Phase 3)UnknownNCT04321616
What this trial is testing

The Efficacy of Different Anti-viral Drugs in COVID 19 Infected Patients

Who this might be right for
SARS-CoV InfectionCOVID 19Acute Respiratory Distress Syndrome ARDS
Oslo University Hospital 700
Large-scale testing (Phase 3)WithdrawnNCT04351516
What this trial is testing

Test and Treat COVID 65plus+

Who this might be right for
SARS-CoV 2COVID-19
University Hospital Tuebingen
Not applicableActive Not RecruitingNCT05443607
What this trial is testing

Transplacental Transmission of RSV (TTRSV)

Who this might be right for
SARS CoV 2 InfectionRespiratory Syncytial Virus (RSV)Bronchiolitis+1 more
Tulane University 300
Testing effectiveness (Phase 2)Study completedNCT04590547
What this trial is testing

GLS-1027 for the Prevention of Severe Pneumonitis Caused by SARS-CoV-2 Infection (COVID-19)

Who this might be right for
PneumonitisSARS-CoV Infection
GeneOne Life Science, Inc. 132
Large-scale testing (Phase 3)UnknownNCT04656613
What this trial is testing

A Phase III Clinical Trial of the Immunogenicity and Safety of the Gam-COVID-Vac Vaccine Against COVID-19 in the UAE

Who this might be right for
Covid19SARS-CoV Infection
Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation 1,000
Not applicableApproved For MarketingNCT04323761
What this trial is testing

Expanded Access Treatment Protocol: Remdesivir (RDV; GS-5734) for the Treatment of SARS-CoV2 (CoV) Infection (COVID-19)

Who this might be right for
SARS-CoV2 Infection
Gilead Sciences
Early research (Phase 1)Study completedNCT04482686
What this trial is testing

Trial of Combination Therapy to Treat COVID-19 Infection

Who this might be right for
COVIDCovid-19Corona Virus Infection+4 more
ProgenaBiome 31
Testing effectiveness (Phase 2)Study completedNCT04530357
What this trial is testing

Reactogenicity, Safety and Immunogenicity of QazCovid-in® COVID-19 Vaccine

Who this might be right for
Covid19SARS-CoV InfectionVaccine Adverse Reaction
Research Institute for Biological Safety Problems 244
Next Page